Manufacturer Communications: Industry Seeks Single Evidentiary Standard
Executive Summary
‘Competent and reliable scientific evidence’ standard for payer communications also should apply to medical product communications that are consistent with labeling, manufacturers say in comments on US FDA draft guidance documents.
You may also be interested in...
'Off-Label' Communications That Are Still 'Consistent' With Labeling Get Better Defined
US FDA's final guidance provides more examples of data that meets the 'scientifically appropriate and statistically sound' standard.
Industry Communications With Payors: US FDA Okays Info On Investigational Drugs
Draft guidance provides clarity on what health care economic information firms can provide to payors, formulary committees and similar entities.
Off-Label Communication: When Does It Align With Approved Labeling?
US FDA draft guidance offers three-factor test to determine when communication about a medical product is consistent with labeling; information on patient-reported outcomes and mechanism of action are okay.